Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure

Aim. To investigate the association between plasma levels of galectin-3 and parameters of endogenous inflammation and nitrosylation oxidative stress (NOS) in patients with decompensated chronic heart failure (CHF). Material and methods. In total, 197 CHF patients with myocardial infarction in medica...

Full description

Bibliographic Details
Main Authors: Yu. B. Shchukin, I. I. Berezin, E. A. Medvedeva, E. I. Seleznev, V. A. Dyachkov, L. N. Slatova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2013-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/362
_version_ 1797857112329551872
author Yu. B. Shchukin
I. I. Berezin
E. A. Medvedeva
E. I. Seleznev
V. A. Dyachkov
L. N. Slatova
author_facet Yu. B. Shchukin
I. I. Berezin
E. A. Medvedeva
E. I. Seleznev
V. A. Dyachkov
L. N. Slatova
author_sort Yu. B. Shchukin
collection DOAJ
description Aim. To investigate the association between plasma levels of galectin-3 and parameters of endogenous inflammation and nitrosylation oxidative stress (NOS) in patients with decompensated chronic heart failure (CHF). Material and methods. In total, 197 CHF patients with myocardial infarction in medical history were divided into 3 groups: Group 1 (n=56) with Functional Class (FC) II CHF IIA; Group 2 (n=72) with FC III CHF IIA; and Group 3 (n=69) with FC IV CHF IIB. The control group (CG) included 39 healthy individuals. Plasma levels of galectin-3, 3-nitrotyrosine, low-density lipoprotein (LDL) oxidation, EC-SOD activity, interleukin-6, and high-sensitivity C-reactive protein (hsCRP) were measured. Results. In Groups 1, 2, and 3, plasma levels of galectin-3 were significantly higher than in CG: by 39% (p<0,05), 164% (p<0,001), and 428% (p<0,001), respectively. The activity of NOS increased in parallel with CHF FC: by 24% (p<0,05) in Group 1, by 81% (p<0,01) in Group 2, and by 152% (p<0,001) in Group 3. There was a strong positive correlation between galectin-3 and 3-nitrotyrosin and between galectin-3 and LDL oxidation across all three groups. The activity of endogenous inflammation also increased in parallel with CHF FC. A strong positive correlation between galectin-3 and hsCRP, as well as between galectin-3 and interleukin-6, was also observed. Conclusion. Galectin-3 levels correlate with CHF severity and are associated with the key parameters of NOS and endogenous inflammationn. Therefore, galectin-3 could be regarded as a marker and mediator of these pathological processes.
first_indexed 2024-04-09T20:51:23Z
format Article
id doaj.art-c6637c4716654684839a5edb4776f8a3
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:51:23Z
publishDate 2013-04-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-c6637c4716654684839a5edb4776f8a32023-03-29T21:23:20Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202013-04-0102454910.15829/1560-4071-2013-2-45-49362Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failureYu. B. Shchukin0I. I. Berezin1E. A. Medvedeva2E. I. Seleznev3V. A. Dyachkov4L. N. Slatova5Samara State Medical Academy, SamaraSamara State Medical Academy, SamaraSamara State Medical Academy, SamaraSamara State Medical Academy, SamaraSamara State Medical Academy, SamaraSamara State Medical Academy, SamaraAim. To investigate the association between plasma levels of galectin-3 and parameters of endogenous inflammation and nitrosylation oxidative stress (NOS) in patients with decompensated chronic heart failure (CHF). Material and methods. In total, 197 CHF patients with myocardial infarction in medical history were divided into 3 groups: Group 1 (n=56) with Functional Class (FC) II CHF IIA; Group 2 (n=72) with FC III CHF IIA; and Group 3 (n=69) with FC IV CHF IIB. The control group (CG) included 39 healthy individuals. Plasma levels of galectin-3, 3-nitrotyrosine, low-density lipoprotein (LDL) oxidation, EC-SOD activity, interleukin-6, and high-sensitivity C-reactive protein (hsCRP) were measured. Results. In Groups 1, 2, and 3, plasma levels of galectin-3 were significantly higher than in CG: by 39% (p<0,05), 164% (p<0,001), and 428% (p<0,001), respectively. The activity of NOS increased in parallel with CHF FC: by 24% (p<0,05) in Group 1, by 81% (p<0,01) in Group 2, and by 152% (p<0,001) in Group 3. There was a strong positive correlation between galectin-3 and 3-nitrotyrosin and between galectin-3 and LDL oxidation across all three groups. The activity of endogenous inflammation also increased in parallel with CHF FC. A strong positive correlation between galectin-3 and hsCRP, as well as between galectin-3 and interleukin-6, was also observed. Conclusion. Galectin-3 levels correlate with CHF severity and are associated with the key parameters of NOS and endogenous inflammationn. Therefore, galectin-3 could be regarded as a marker and mediator of these pathological processes.https://russjcardiol.elpub.ru/jour/article/view/362chronic heart failuregalectin-3inflammationnitrosylation oxidative stress
spellingShingle Yu. B. Shchukin
I. I. Berezin
E. A. Medvedeva
E. I. Seleznev
V. A. Dyachkov
L. N. Slatova
Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
Российский кардиологический журнал
chronic heart failure
galectin-3
inflammation
nitrosylation oxidative stress
title Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
title_full Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
title_fullStr Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
title_full_unstemmed Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
title_short Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
title_sort galectin 3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
topic chronic heart failure
galectin-3
inflammation
nitrosylation oxidative stress
url https://russjcardiol.elpub.ru/jour/article/view/362
work_keys_str_mv AT yubshchukin galectin3asamarkerandmediatorofendogenousinflammationandnitrosylationoxidativestressinpatientswithchronicheartfailure
AT iiberezin galectin3asamarkerandmediatorofendogenousinflammationandnitrosylationoxidativestressinpatientswithchronicheartfailure
AT eamedvedeva galectin3asamarkerandmediatorofendogenousinflammationandnitrosylationoxidativestressinpatientswithchronicheartfailure
AT eiseleznev galectin3asamarkerandmediatorofendogenousinflammationandnitrosylationoxidativestressinpatientswithchronicheartfailure
AT vadyachkov galectin3asamarkerandmediatorofendogenousinflammationandnitrosylationoxidativestressinpatientswithchronicheartfailure
AT lnslatova galectin3asamarkerandmediatorofendogenousinflammationandnitrosylationoxidativestressinpatientswithchronicheartfailure